Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2017 (2017), Article ID 9249302, 5 pages
https://doi.org/10.1155/2017/9249302
Case Report

Myelodysplasia and Mast Cell Leukemia with t(9;22)

1Internal Medicine Service, San Antonio Military Medical Center, Fort Sam Houston, San Antonio, TX, USA
2Hematology and Oncology Service, San Antonio Military Medical Center, Fort Sam Houston, San Antonio, TX, USA
3Department of Pathology, University of Texas Health Science Center, San Antonio, TX, USA

Correspondence should be addressed to Kathryn J. Lago

Received 28 July 2017; Revised 13 October 2017; Accepted 25 October 2017; Published 26 November 2017

Academic Editor: Peter F. Lenehan

Copyright © 2017 Kathryn J. Lago et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Georgin-Lavialle, L. Lhermitte, P. Dubreuil, M.-O. Chandesris, O. Hermine, and G. Damaj, “Mast cell leukemia,” Blood, vol. 121, no. 8, pp. 1285–1295, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Swerdlow, E. Campo, N. L. Harris et al., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Internal Agency for Research on Cancer, Lyon, France, 4th edition, 2008.
  3. H. P. Horny, K. Sotlar, P. Valent, and K. Hartmann, “Mastocytosis: a disease of the hematopoietic stem cell,” Deutsches Ärzteblatt International, vol. 105, no. 40, pp. 686–692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. W. Vardiman, N. L. Harris, and R. D. Brunning, “The World Health Organization (WHO) classification of the myeloid neoplasm,” Blood, vol. 100, no. 7, pp. 2292–2302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. ISCN, ISCN 2009: An International System for Human Cytogenetic Nomenclature, L. G. Shaffer, M. L. Slovak, and L. J. Campbell, Eds., Karger, Basel, Switzerland, 2009.
  6. M. Miettinen and J. Lasota, “KIT (CD117): a review of expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation,” Applied Immunohistochemistry & Molecular Morphology, vol. 13, no. 3, pp. 205–220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Kurzrock, H. M. Kantarjian, B. J. Druker, and M. Talpaz, “Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics,” Annals of Internal Medicine, vol. 138, no. 10, pp. 819–830, 2003. View at Publisher · View at Google Scholar
  8. A. Rojas-Atencio, K. Urdaneta, M. Soto-Quintana, F. A. Nava, J. Cañizales, and E. Solis, “Trisomy 19 and t(9;22) in a patient with acute basophilic leukemia,” Case Reports in Pathology, vol. 2011, Article ID 269491, 3 pages, 2011. View at Publisher · View at Google Scholar
  9. K. Hussein, H. P. Horny, G. Büsche et al., “Systemic mastocytosis with associated BCR-ABL positive myelogenous leukaemia: evidence that mast cells do not belong to the leukaemic clone,” Leukemia, vol. 25, no. 6, pp. 1050–1053, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Arber, A. Orazi, R. Hasserjian et al., “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia,” Blood, vol. 127, no. 20, pp. 2391–2405, 2016. View at Publisher · View at Google Scholar · View at Scopus